Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Subhasree Kar

THE TRUTH ABOUT: Is bionano genomics bngo a buy or sell this week - The Untold Story

Bionano Genomics, Inc. (BNGO) has garnered attention with its Saphyr system, a third-generation optical mapping solution offering quick, high-throughput, long-range genome mapping and structural variation detection capabilities critical for genomic research. The number of installed Saphyr systems reached 259 as of the first quarter of 2023, marking a 47% increase compared to the same period last year.

“We are leveraging our investments in the commercial organization and evidence development to drive adoption of the Saphyr system,” stated Chris Stewart, Bionano’s Chief Financial Officer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.